3rd Microbiome R&D and Business Collaboration Congress: Asia
Nick West, Research Fellow, Mucosal Immunology Research Group. Grifiith University Australia will talk about the latest research on the use of probiotics for allergy; Winclove's formulation Ecologic® AllergyCare
Wednesday March 1, 13.00-13.30
NICHOLAS WEST Research Fellow, Mucosal Immunology Research Group, Griffith University, Australia.
Probiotics for allergy care: growing evidence of benefit
The benefit of probiotics is based on growing knowledge that the gut microbiota plays an important role in health and disease. Reduced microbial diversity is considered a key factor in the increase in allergies observed in developed countries. The World Allergy Organisation recommends the use of probiotics for the primary prevention of eczema while clinical trial evidence indicates a moderate benefit for allergy in a number of population groups. This talk will review the latest research on the use of probiotics for allergy, limitations to the research and whether sufficient evidence is available for clinical recommendations on the use of probiotic supplements in allergy. (Source Global Engage)
Visit Microbiome R&D and Business Collaboration Congress
Klik op het menu voor inhoud en andere functies.
Gebruik de pijlen aan de zijkant om door het magazine te bladeren.